<- Go Home
Labiana Health, S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments, quality system and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
Market Cap
EUR 55.4M
Volume
6.3K
Cash and Equivalents
EUR 3.8M
EBITDA
EUR 9.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 40.7M
Profit Margin
56.74%
52 Week High
EUR 8.20
52 Week Low
EUR 3.34
Dividend
N/A
Price / Book Value
10.26
Price / Earnings
51.82
Price / Tangible Book Value
10.92
Enterprise Value
EUR 86.6M
Enterprise Value / EBITDA
9.23
Operating Income
EUR 6.3M
Return on Equity
23.11%
Return on Assets
7.43
Cash and Short Term Investments
EUR 3.8M
Debt
EUR 36.0M
Equity
EUR 3.6M
Revenue
EUR 71.7M
Unlevered FCF
EUR 3.9M
Sector
Pharmaceuticals
Category
N/A